(Q49094301)

English

Volumetric Arc Therapy and Intensity-Modulated Radiotherapy for Primary Prostate Radiotherapy With Simultaneous Integrated Boost to Intraprostatic Lesion With 6 and 18 MV: A Planning Comparison Study

scientific article published on August 2, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Volumetric Arc Therapy and Intensity-Modulated Radiotherapy for Primary Prostate Radiotherapy With Simultaneous Integrated Boost to Intraprostatic Lesion With 6 and 18 MV: A Planning Comparison Study (English)

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

adaptive radiation therapy

0 references

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20675077

14 June 2024

author name string

Piet Ost

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Bruno Speleers

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Gert De Meerleer

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Wilfried De Neve

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Valérie Fonteyne

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Geert Villeirs

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Werner De Gersem

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

language of work or name

0 references

publication date

2 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301610006012?httpAccept=text/xml

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

https://api.elsevier.com/content/article/PII:S0360301610006012?httpAccept=text/plain

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

79

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

920-926

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

2

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

3

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer

4

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning

5

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy

6

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients

7

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

8

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy

9

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.

10

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.

11

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Quasi-IMAT technique and secondary cancer risk in prostate cancer.

12

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

RapidArc volumetric modulated therapy planning for prostate cancer patients

13

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy

14

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer

15

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours

16

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.

17

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.

18

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy

19

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

The impact of IMRT and proton radiotherapy on secondary cancer incidence.

20

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging

21

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.

22

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients

23

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer

24

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.

25

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method

26

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Leaf position optimization for step-and-shoot IMRT.

28

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience.

29

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

30

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial

31

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.

32

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

34

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

36

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Fitting of normal tissue tolerance data to an analytic function

37

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans

38

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

What dose of external-beam radiation is high enough for prostate cancer?

39

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer

40

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Urinary Obstruction in Prostate Cancer Patients From the Dutch Trial (68 Gy vs. 78 Gy): Relationships With Local Dose, Acute Effects, and Baseline Characteristics

41

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review

42

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy.

43

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate.

44

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery

45

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Radiation-induced second cancers: the impact of 3D-CRT and IMRT

46

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Integral radiation dose to normal structures with conformal external beam radiation

47

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Nontumor integral dose variation in conventional radiotherapy treatment planning

48

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets

49

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.

50

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.

51

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

IMRT should not be administered at photon energies greater than 10MV

52

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

X-ray depth doses from linear accelerators in the energy range from 10 to 32 Mev

53

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy

54

1 reference

10.1016/J.IJROBP.2010.04.025

https://api.crossref.org/works/10.1016/J.IJROBP.2010.04.025

14 June 2024

Identifiers

10.1016/J.IJROBP.2010.04.025

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20675077

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49094301&oldid=2179114397"